Journals / E Journal of Cardiovascular Medicine / 2021 / Cilt: 9 - Sayı: 3

Patients with Vitamin D Deficiency Are at Higher Risk of Developing Calcified and Mixed Plaques

Pages
158–168
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A negative correlation was detected between the vitamin D levels and CACSs (r=0.345; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Vitamin D plays a role in the cardiovascular system through its pleomorphic effects.
📊
Key Findings & Data:Materials and Methods: Included in this retrospective cohort study were 719 patients who had no previously known coronary artery disease (CVD), and for whom coronary computed tomography angiography (CCTA) was performed between 2015 and 2019.
💡
Conclusion & Impact:A negative correlation was detected between the vitamin D levels and CACSs (r=0.345; p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Vitamin D plays a role in the cardiovascular system through its pleomorphic effects. In some studies, it has been reported that the relationship between vitamin D deficiency and coronary artery calcification is inconsistent. In this study, it was aimed to evaluate the relationship between the vitamin D level and coronary artery calcium score (CACS), plaque presence, and plaque type. Materials and Methods: Included in this retrospective cohort study were 719 patients who had no previously known coronary artery disease (CVD), and for whom coronary computed tomography angiography (CCTA) was performed between 2015 and 2019. Patients were classified as normal, inadequate, or deficient according to their levels of vitamin D deficiency. They were evaluated according to the presence of plaque on their CCTA or CACS >0 atherosclerosis. Moreover, patients were separated into four groups, comprising zero-plaque (those that were not plaque according to the plaque type), mere fatty plaque (CACS=0), mere calcified plaque, and mixed plaque. Age, sex, smoking status, diabetes mellitus, hypertension, and hyperlipidemia were evaluated as traditional risk factors. Results: In 18.4% of the patients, the vitamin D levels were normal, whereas they were inadequate in 65% and deficient in 16.7%. The median CACS of the patients was 0 (range: 0-3759), and mere fatty plaque was found in 13.5% of patients,whereas 13.4% had mere calcified plaque, and 27.5% had mixed plaque. A negative correlation was detected between the vitamin D levels and CACSs (r=0.345; p

🔖

Cite This Article

YILDIRIM, O., ALTINTAŞ, M. S., YÜKSEL, Y., EYYÜPKOCA, F., KOÇAK, A. (2022). Patients with Vitamin D Deficiency Are at Higher Risk of Developing Calcified and Mixed Plaques. E Journal of Cardiovascular Medicine, Cilt: 9 - Sayı: 3, 158–168. https://ajindex.com/articles/498215

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11
  2. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005;94:483-92
  3. Dziedzic EA, Gąsior JS, Pawłowski M, et al. Vitamin D level is associated with severity of coronary artery atherosclerosis and incidence of acute coronary syndromes in non-diabetic cardiac patients. Arch Med Sci 2019;15:359-68
  4. Carbone F, Montecucco F. The role of the intraplaque vitamin d system in atherogenesis. Scientifica (Cairo) 2013;2013:620504
  5. Brewer LC, Michos ED, Reis JP. Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets 2011;12:54-60
  6. Chen S, Glenn DJ, Ni W, et al. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension 2008;52:1106-12
  7. Pilz S, Tomaschitz A, Drechsler C, Dekker JM, März W. Vitamin D deficiency and myocardial diseases. Mol Nutr Food Res 2010;54:1103-13
  8. Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005;288:E125-32
  9. Budoff MJ, Gul KM. Expert review on coronary calcium. Vasc Health Risk Manag 2008;4:315-24
  10. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005;234:35-43
  11. Doherty TM, Asotra K, Fitzpatrick LA, et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A 2003;100:11201-6
  12. Manson JE, Allison MA, Carr JJ, et al. Calcium/vitamin D supplementation and coronary artery calcification in the Women’s Health Initiative. Menopause 2010;17:683-91
  13. Wang J, Zhou JJ, Robertson GR, Lee VW. Vitamin D in Vascular Calcification: A Double-Edged Sword? Nutrients 2018;10:652
  14. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-38
  15. Malik R, Aneni EC, Roberson L, et al. Measuring coronary artery calcification: is serum vitamin D relevant? Atherosclerosis 2014;237:734-8
  16. Lichtenstein G, Perlman A, Shpitzen S, et